Empowered Funds’s Amedisys AMED Stock Holding History

Empowered Funds’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,979	Closed	-$293K	–	1821
2025 Q2	$293K	Sell	2,979 -875	-23%	-$82.8K	﹤0.01%	1519
2025 Q1	$357K	Buy	3,854 +354	+10%	+$32.6K	0.01%	1351
2024 Q4	$318K	Buy	+3,500	New	+$321K	﹤0.01%	1353
2022 Q4	–	Sell	-2,184	Closed	-$211K	–	447
2022 Q3	$211K	Buy	+2,184	New	+$260K	0.02%	307
2020 Q4	–	Sell	-6,054	Closed	-$1.43M	–	166
2020 Q3	$1.43M	Sell	6,054 -749	-11%	-$170K	0.45%	80
2020 Q2	$1.35M	Buy	+6,803	New	+$1.27M	0.52%	72
2019 Q3	–	Sell	-10,135	Closed	-$1.23M	–	99
2019 Q2	$1.23M	Sell	10,135 -1,487	-13%	-$176K	0.51%	60
2019 Q1	$1.43M	Buy	+11,622	New	+$1.46M	0.51%	76

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Empowered Funds's AMED Position: Q3 2025 in Review

Empowered Funds sold out of Amedisys (AMED) in Q3 2025, closing a stake of 2,979 shares — an estimated $293K sold.

Empowered Funds first reported a position in AMED in Q1 2019 and held it in 8 quarters. The position peaked at $1.43M in Q1 2019. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

Empowered Funds reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
Empowered Funds sold 2,979 Amedisys shares in Q3 2025, an estimated $293K.
Empowered Funds first reported a position in Amedisys in Q1 2019 and held it in 8 quarters.
Empowered Funds's Amedisys position peaked at $1.43M in Q1 2019.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Empowered Funds's 13F filing for Q3 2025, filed 13 Nov 2025.